annual EBITDA:
-$99.19M+$13.11M(+11.67%)Summary
- As of today (May 29, 2025), STOK annual EBITDA is -$99.19 million, with the most recent change of +$13.11 million (+11.67%) on December 31, 2024.
- During the last 3 years, STOK annual EBITDA has fallen by -$14.10 million (-16.58%).
- STOK annual EBITDA is now -1723.10% below its all-time high of -$5.44 million, reached on December 31, 2017.
Performance
STOK EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$111.72M+$124.84M(+951.05%)Summary
- As of today (May 29, 2025), STOK quarterly EBITDA is $111.72 million, with the most recent change of +$124.84 million (+951.05%) on March 31, 2025.
- Over the past year, STOK quarterly EBITDA has increased by +$139.53 million (+501.73%).
- STOK quarterly EBITDA is now at all-time high.
Performance
STOK quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$40.33M+$139.53M(+140.66%)Summary
- As of today (May 29, 2025), STOK TTM EBITDA is $40.33 million, with the most recent change of +$139.53 million (+140.66%) on March 31, 2025.
- Over the past year, STOK TTM EBITDA has increased by +$156.35 million (+134.76%).
- STOK TTM EBITDA is now at all-time high.
Performance
STOK TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
STOK EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.7% | +501.7% | +134.8% |
| 3 y3 years | -16.6% | +555.1% | +143.3% |
| 5 y5 years | -181.6% | +1067.9% | +199.5% |
STOK EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -16.6% | +11.7% | at high | +442.1% | at high | +134.8% |
| 5 y | 5-year | -181.6% | +11.7% | at high | +442.1% | at high | +134.8% |
| alltime | all time | -1723.1% | +11.7% | at high | +442.1% | at high | +134.8% |
STOK EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $111.72M(-951.0%) | $40.33M(-140.7%) |
| Dec 2024 | -$99.19M(-11.7%) | -$13.13M(-55.4%) | -$99.19M(-13.8%) |
| Sep 2024 | - | -$29.46M(+2.3%) | -$115.03M(+2.6%) |
| Jun 2024 | - | -$28.79M(+3.5%) | -$112.16M(-3.3%) |
| Mar 2024 | - | -$27.81M(-4.0%) | -$116.02M(+3.3%) |
| Dec 2023 | -$112.30M(+9.2%) | -$28.96M(+8.9%) | -$112.30M(+2.2%) |
| Sep 2023 | - | -$26.60M(-18.5%) | -$109.91M(-0.1%) |
| Jun 2023 | - | -$32.65M(+35.5%) | -$110.07M(+7.5%) |
| Mar 2023 | - | -$24.09M(-9.3%) | -$102.36M(-0.4%) |
| Dec 2022 | -$102.81M(+20.8%) | -$26.57M(-0.7%) | -$102.81M(+2.3%) |
| Sep 2022 | - | -$26.76M(+7.3%) | -$100.53M(+4.5%) |
| Jun 2022 | - | -$24.94M(+1.6%) | -$96.20M(+3.4%) |
| Mar 2022 | - | -$24.55M(+1.1%) | -$93.05M(+9.4%) |
| Dec 2021 | -$85.09M | -$24.29M(+8.3%) | -$85.09M(+13.2%) |
| Sep 2021 | - | -$22.43M(+3.0%) | -$75.15M(+13.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | -$21.78M(+31.3%) | -$66.20M(+15.7%) |
| Mar 2021 | - | -$16.59M(+15.6%) | -$57.20M(+9.7%) |
| Dec 2020 | -$52.16M(+48.1%) | -$14.35M(+6.5%) | -$52.16M(+7.0%) |
| Sep 2020 | - | -$13.48M(+5.4%) | -$48.74M(+8.4%) |
| Jun 2020 | - | -$12.79M(+10.8%) | -$44.98M(+11.0%) |
| Mar 2020 | - | -$11.54M(+5.6%) | -$40.53M(+15.0%) |
| Dec 2019 | -$35.23M(+180.3%) | -$10.93M(+12.5%) | -$35.23M(+22.5%) |
| Sep 2019 | - | -$9.72M(+16.5%) | -$28.77M(+29.0%) |
| Jun 2019 | - | -$8.34M(+33.6%) | -$22.30M(+31.7%) |
| Mar 2019 | - | -$6.24M(+39.7%) | -$16.93M(+34.7%) |
| Dec 2018 | -$12.57M(+131.0%) | -$4.47M(+37.3%) | -$12.57M(+55.1%) |
| Sep 2018 | - | -$3.25M(+9.6%) | -$8.10M(+67.1%) |
| Jun 2018 | - | -$2.97M(+57.8%) | -$4.85M(+157.8%) |
| Mar 2018 | - | -$1.88M | -$1.88M |
| Dec 2017 | -$5.44M | - | - |
FAQ
- What is Stoke Therapeutics annual EBITDA?
- What is the all time high annual EBITDA for Stoke Therapeutics?
- What is Stoke Therapeutics annual EBITDA year-on-year change?
- What is Stoke Therapeutics quarterly EBITDA?
- What is the all time high quarterly EBITDA for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly EBITDA year-on-year change?
- What is Stoke Therapeutics TTM EBITDA?
- What is the all time high TTM EBITDA for Stoke Therapeutics?
- What is Stoke Therapeutics TTM EBITDA year-on-year change?
What is Stoke Therapeutics annual EBITDA?
The current annual EBITDA of STOK is -$99.19M
What is the all time high annual EBITDA for Stoke Therapeutics?
Stoke Therapeutics all-time high annual EBITDA is -$5.44M
What is Stoke Therapeutics annual EBITDA year-on-year change?
Over the past year, STOK annual EBITDA has changed by +$13.11M (+11.67%)
What is Stoke Therapeutics quarterly EBITDA?
The current quarterly EBITDA of STOK is $111.72M
What is the all time high quarterly EBITDA for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly EBITDA is $111.72M
What is Stoke Therapeutics quarterly EBITDA year-on-year change?
Over the past year, STOK quarterly EBITDA has changed by +$139.53M (+501.73%)
What is Stoke Therapeutics TTM EBITDA?
The current TTM EBITDA of STOK is $40.33M
What is the all time high TTM EBITDA for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM EBITDA is $40.33M
What is Stoke Therapeutics TTM EBITDA year-on-year change?
Over the past year, STOK TTM EBITDA has changed by +$156.35M (+134.76%)